Join in the conversation with #BBRFWebinar!
Learn more about this webinar at: [ Ссылка ]
Each month The Brain & Behavior Research Foundation (BBRF) hosts a Meet the Scientist Webinar featuring a researcher discussing the latest findings related to mental illness.
In August 2013, BBRF featured the research of Dr. Carlos A. Zarate, Jr. of the National Institute of Mental Health. He presented KETAMINE AND NEXT GENERATION THERAPIES.
Dr. Zarate, M.D., a NARSAD Independent Investigator Grantee (2005), has pioneered revolutionary studies that have led to novel treatments for mood disorders such as depression and bipolar disorder that begin working much faster than previous options. Dr. Zarate is Chief of Experimental Therapeutics of the Mood and Anxiety Disorders Program at the National Institute of Mental Health (NIMH), and Clinical Professor of Psychiatry and Behavioral Sciences at George Washington University. With a strong focus on the pathophysiology of severe mental illnesses, his goal is to develop better treatments particularly for patients living with depression, bipolar disorder and/or other mood disorders. His research into a drug called Ketamine has resulted in rapid-acting depression treatments that work within hours and last 3-5 days or more. Because of the speed at which this drug reacts within the body and the duration of its effects, it is possible that emergency room doctors may have a possible treatment for those suffering from depression and acute suicidality.
Find recordings of past BBRF Webinars and register for upcoming Meet the Scientist Webinars here: [ Ссылка ]
Learn more about BBRF and donate to support mental health research: [ Ссылка ]
Remember 100% of your donation for research is invested in research grants thanks to the generosity of two family foundations that cover Foundation operating expenses.
We encourage you to share this presentation! #BBRFWebinar
